Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Net sales $ 521,060 $ 84,300
Cost of sales 6,225,299 1,747,975
Gross loss (5,704,239) (1,663,675)
Operating expenses    
Selling, general and administrative 6,885,830 5,565,787
Research and development 3,863,715 1,902,236
Total operating expenses 10,749,545 7,468,023
Other (loss) income (136,605,952) 864,900
Loss from operations (153,059,736) (8,266,798)
Interest income, net (14,920,473) (13,023,489)
(Loss) income before provision (benefit) for income taxes (138,139,263) 4,756,691
Provision (benefit) for income taxes (17,632,492) 0
Net (loss) income $ (120,506,771) $ 4,756,691
Net (loss) income per share of common stock - basic (in usd per share) $ (0.98) $ 0.07
Net (loss) income per share of common stock - diluted (in usd per share) $ (1.04) $ 0.06
Weighted average number of common shares outstanding - basic (in shares) 122,633,856 68,465,759
Weighted average number of common shares outstanding - diluted (in shares) 128,301,184 83,768,820